DanioLabs
Cambridge
About DanioLabs
DanioLabs Ltd. discovers and develops therapeutics for neurological, ophthalmologic, metabolic, and gastrointestinal diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Total funding: $7.7M
- Funding stage: M&A
- Last round: Grant (Jun 2005)
Industries & Categories
Biotechnology, Clinical Trials, Medical, Therapeutics
Canonical: https://fsome.com/organization/daniolabs-2760697 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.